Advanced Enzyme Financial Statements

Advanced Enzyme (ADVENZYMES) reported revenue of ₹7.46B in FY2026 with net income of ₹1.74B. Total assets stood at ₹18.39B. Net worth was ₹16.32B (₹1,632 Cr) and free cash flow was ₹1.05B.

Advanced Enzyme Income Statement

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026

Item	Chart	2025	2026
Revenue		6.37B	7.46B
Cost of Rev. Cost of Revenue		-1.52B	-1.93B
Gross Profit		4.85B	5.53B
SGA Sales, General & Admin		-1.42B	-3.24B
Op. Income Operating Income		1.58B	1.89B
PBT Profit Before Tax		1.87B	2.33B
Net Income		1.31B	1.74B
Dil. Shares Diluted Shares		111.99M	112.04M
Diluted EPS		11.71	15.06

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Advanced Enzyme's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Advanced Enzyme Balance Sheet

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026

Item	Chart	2025	2026
Curr. assets Total current assets		8.80B	10.44B
Non-curr. assets Total non-current assets		7.41B	7.95B
Total assets		16.21B	18.39B
Curr. liabilities Total current liabilities		967.55M	1.07B
Non-curr. liab. Total non-current liabilities		559.22M	489.17M
Total liabilities		1.53B	1.56B
Total equity		14.69B	16.83B
Total liab. & eq. Total liabilities & equity		16.21B	18.39B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Advanced Enzyme's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Advanced Enzyme Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026

Item	Chart	2025	2026
Net Income		1.87B	2.33B
Operating CF Cash flow Operating Activities		1.42B	1.57B
Capex Investments in PPE		-338.08M	-522.30M
Investing CF Cash flow Investing Activities		-891.01M	-741.30M
Dividend Paid		-590.30M	-597.78M
Financing CF Cash flow Financing Activities		-725.44M	-703.66M
Cash (start) Cash at beginning of period		1.14B	942.25M
Cash (end) Cash at end of period		942.25M	1.09B
FCF Free Cash Flow		1.09B	1.05B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Advanced Enzyme's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2026